/* Google Analytics Code asynchronous */

Saturday, July 21, 2007

President Gets "Socialized" Colonoscopy for "Free" - Uninsured pay $1,000 or more

Sort of says it all:

Currently, 18 states require coverage of colorectal cancer screening tests. A few other states require that they be offered or available through Medicare Supplemental policies. The map below summarizes 50-state colorectal cancer screening requirements.

But does it? To wit:

American Indian Women are 1.9 times as likely to die from cervical cancer as compared to white women.

Asian/Pacific Islander men and women have higher incidence and mortality rates for stomach and liver cancer.

In 2003, Hispanic women were 2.2 times as likely as non-Hispanic white women to be diagnosed with cervical cancer.

The new Supreme Court Justices think that these categories of people no longer matter in Amerika ... zzzzzzzzzzz

More (I wonder if this ever made it onto Laura Bush's 'to do' list or if it was too 'anti-business'):

An Overview of State Legislative Mandates for Insurance Coverage for Screening and Treatment Services for Certain Cancers in Women
(2003).

PRINCIPAL FINDINGS: State legislative activity varies greatly by the type of cancer being addressed. To date, the area of reimbursement for screening mammography has generated the greatest volume of cancer-control legislation monitored by the SCLD Program. While nearly every state (including the District of Columbia) has enacted measures related to insurance coverage for breast cancer screening, less than one-half of the states have laws requiring coverage for cervical cancer screening and only one-third have laws requiring coverage for colorectal cancer screening tests. Nearly all of the legislative activity related to treatment reimbursement and followup has focused on breast cancer. With the exception of breast cancer treatment reimbursement laws (inpatient care, reconstructive surgery, prosthetic devices, and lymphedema therapy) there are few state mandates for treatment coverage for colorectal and cervical cancers. At this time, there is minimal legislative activity related to ovarian and uterine cancer screening and treatment reimbursement.